These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 15924808)

  • 1. [Changes in gelatinases expression and activity in human atria during atrial fibrillation].
    Ke D; Xu CX; Zhang JC; Chen L; Lin YZ; Lin LF; Hu XZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):137-42. PubMed ID: 15924808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical on molecular basis of atrial fibrosis in patients with atrial fibrillation investigation].
    Ke D; Xu CX; Lin YZ; Zhang JC; Chen L; Lin LF; Hu XZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):459-63. PubMed ID: 15932710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of matrix metalloproteinase-9 and tissue inhibitor-1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation].
    Zhu H; Zhang W; Guo CH; Zhang G; Zhang WD; Zhong M; Yang GR; Ge ZM; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):45-8. PubMed ID: 15808077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between atrial fibroblast proliferation/fibrosis and atrial fibrillation in patients with rheumatic heart disease].
    Lin YZ; Cai JM; Chen L; Yang ZP; Zhang JC; Wu W; Ke D; Xu CX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):813-7. PubMed ID: 20128380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation.
    Nakano Y; Niida S; Dote K; Takenaka S; Hirao H; Miura F; Ishida M; Shingu T; Sueda T; Yoshizumi M; Chayama K
    J Am Coll Cardiol; 2004 Mar; 43(5):818-25. PubMed ID: 14998623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
    Chen CL; Huang SK; Lin JL; Lai LP; Lai SC; Liu CW; Chen WC; Wen CH; Lin CS
    J Mol Cell Cardiol; 2008 Dec; 45(6):742-53. PubMed ID: 18692064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
    Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
    Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
    Wang W; Zhang HT; Yang XL
    J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation.
    Xu J; Cui G; Esmailian F; Plunkett M; Marelli D; Ardehali A; Odim J; Laks H; Sen L
    Circulation; 2004 Jan; 109(3):363-8. PubMed ID: 14732752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of mineralocorticoid receptor and 11-beta-hydroxysteroid dehydrogenase type 2 in human atria during chronic atrial fibrillation: study of 25 cases].
    Pei DA; Li L; Xu ZY; Zou LJ; Zhang BR; Huang SD; Hao JH; Wang ZN; Lu FL
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):816-9. PubMed ID: 17565863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Collagen type I and interleukin-1 beta gene expression in human atria during atrial fibrillation].
    Wu W; Ke D; Xu CX; Deng YL; Chen L; Zhang JC; Lin YZ; Hu XZ
    Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):807-10. PubMed ID: 17217743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of matrix metalloproteinase and tissue inhibitor of metalloproteinase in atrial structural remodeling in patients with atrial fibrillation].
    Wang W; Wu PS; Yang XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1160-2. PubMed ID: 20501421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of disequilibrium of expression of matrix metalloproteinase-2/9 and their tissue inhibitors in pathogenesis of hyperoxia-induced acute lung injury in mice].
    Zhang XF; Zhu GF; Liu S; Foda HD
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Oct; 20(10):597-600. PubMed ID: 18926070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease.
    Gai X; Zhang Z; Liang Y; Chen Z; Yang X; Hou J; Lan X; Zheng W; Hou J; Huang M
    Clin Chim Acta; 2010 May; 411(9-10):719-24. PubMed ID: 20138860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression during atrial structural remodeling in human left and right atrial appendages in atrial fibrillation.
    Zhu H; Zhang W; Zhong M; Zhang G; Zhang Y
    Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):535-41. PubMed ID: 21659381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia].
    Zhang H; Lin QD; Qiao C
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):509-13. PubMed ID: 17083831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation.
    Gramley F; Lorenzen J; Plisiene J; Rakauskas M; Benetis R; Schmid M; Autschbach R; Knackstedt C; Schimpf T; Mischke K; Gressner A; Hanrath P; Kelm M; Schauerte P
    J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1076-82. PubMed ID: 17655664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.
    Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W
    Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.